Guillain–Barré syndrome – Literature overview

Conclusions Diagnosis and treatment of GBS are crucial issues in clinical practice, because approximately 25% of patients can develop respiratory failure, significant disability followed by GBS present in 20%, and chronic fatigue in 60%–70% of patients. Despite symptomatic treatment and immunotherapy, mortality associated with GBS still ranges from 4% to 15%.
Source: Polish Annals of Medicine - Category: Journals (General) Source Type: research